Navigation Links
BrightFocus Foundation announces $7.2 million in grants for Alzheimer's and vision disease research
Date:7/10/2013

Clarksburg, MDBrightFocus Foundation, a nonprofit organization that funds innovative, early-stage research on Alzheimer's disease and the vision diseases of glaucoma and macular degeneration, today announced grant awards totaling more than $7.2 million to 53 scientists in 16 states and four foreign countries.

The funded research projects reflect the full range of new tools and innovationsin imaging technology, gene therapy, and cell regenerationthat scientists are using to better understand how diseases of mind and sight develop. Study results could lead to new therapies to prevent or treat these diseases.

"Investment in research has advanced our understanding of Alzheimer's and vision diseases," said BrightFocus President and CEO, Stacy Pagos Haller. "Now, thanks to new developments in genetics, neurology and imaging, the potential for scientists to make groundbreaking research discoveries is taking off. BrightFocus Foundation is more committed than ever to making this cutting-edge research possible, particularly at a time when government research funding levels are stagnant."

BrightFocus has provided $130 million to date in research funding, awarding more than $26 million for research on diseases of mind and sight in the last four years alone. This year's grantees include researchers from across the U.S., as well as Australia, Great Britain, Ireland, and Israel.

Alzheimer's Disease Research

Alzheimer's is a devastating degenerative disease that irreversibly destroys memory and other brain function over time. BrightFocus-funded scientists are studying various ways in which the "memory pathways" in the brainthe systems by which brain cells communicatecan go awry in this disease.

Some researchers are investigating whether certain chemicals control the "switches" to these pathways; others are using highly refined brain imaging or magnetic brain stimulation techniques to learn more about pathways; and some are using cell-based therapies to try to restore the brain circuits made during memory formation. Still others are studying how problems with brain blood flow contribute to Alzheimer's disease.

Glaucoma Research

For all three diseases, scientists want to know how inflammation and the body's immune response system may be involved, making the body turn against healthy cells in the brain or eyes. Several glaucoma researchers are examining the mind-eye connection, and why changes in the brain may contribute to the development of glaucoma long before vision loss occurs. Early detection is particularly important for glaucoma: in the U.S., an estimated half of the three million people with glaucoma may not know they have the disease.

Macular Degeneration Research

New cell-based and gene-based therapies may help stop the nerve damage and the loss of the eye's retinal cells involved in macular degeneration. The latest cell regeneration techniques may allow scientists to restore damaged eye cells or generate new healthy ones. Researchers are also investigating the mysterious presence of micro RNAs, a large group of small molecules that may affect the functioning of the retina in macular degenerationas well as brain functions in Alzheimer's disease.


'/>"/>

Contact: Alice L. Kirkman
akirkman@brightfocus.org
301-556-9349
AHAF-American Health Assistance Foundation
Source:Eurekalert

Related biology news :

1. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
2. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
3. John A. Kaufman named 2012 Dotter Lecturer by Society of Interventional Radiology Foundation
4. Genzyme/ACMG Foundation Genetics Training Award in Clinical Biochemical Genetics announced
5. 2012 ACMG Foundation/Signature Genomic Laboratories Travel Award winner announced
6. ASBMB wins National Science Foundation grant to enhance K-12 science education
7. UF receives $1 million from Keck Foundation to study mechanisms of inherited disease
8. Merkin Family Foundation to fund next generation of Broad Institute scientists
9. Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinsons drug development tools
10. New York Stem Cell Foundation scientist grows bone from human embryonic stem cells
11. National Psoriasis Foundation awards more than $2 million for research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/23/2016)... 23, 2016 ... Gesichts- und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler ... mit SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie ... die Möglichkeit angeboten, im Rahmen mobiler Apps ...
(Date:3/21/2016)... WAKEFIELD, Massachusetts , March 22, 2016 ... and facial recognition with passcodes for superior security ... MESG ), a leading provider of secure digital communications ... pilot their biometric technology and offer enterprise customers, particularly ... provide secure facial recognition and voice authentication within a ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: